Issue navigation
Volume 7, Issue 2, March 2021
Editorials
Antiplatelet treatment in coronary syndrome
Stefan Agewall
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 2, March 2021, Pages 81–82, https://doi.org/10.1093/ehjcvp/pvab015
From glucose lowering to treatment of cardiovascular disease: the repositioning of glucose-lowering agents
Massimiliano Caprio and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 2, March 2021, Pages 83–85, https://doi.org/10.1093/ehjcvp/pvaa019
Original Articles
Thrombosis and antithrombotic therapy
Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials
Stefano Benenati and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 2, March 2021, Pages 86–93, https://doi.org/10.1093/ehjcvp/pvaa001
Acute coronary syndromes
Comparison of P2Y12 receptor inhibitors in patients with ST-elevation myocardial infarction in clinical practice: a propensity score analysis of five contemporary European registries
Leonardo De Luca and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 2, March 2021, Pages 94–103, https://doi.org/10.1093/ehjcvp/pvaa002
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction
Marco Trevisan and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 2, March 2021, Pages 104–111, https://doi.org/10.1093/ehjcvp/pvaa004
Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention
Seung Hun Lee and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 2, March 2021, Pages 112–124, https://doi.org/10.1093/ehjcvp/pvaa005
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Diana A Gorog and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 2, March 2021, Pages 125–140, https://doi.org/10.1093/ehjcvp/pvaa009
Prevention and epidemiology
Low adherence to statin treatment during the 1st year after an acute myocardial infarction is associated with increased 2nd-year mortality risk—an inverse probability of treatment weighted study on 54 872 patients
Kani Khalaf and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 2, March 2021, Pages 141–147, https://doi.org/10.1093/ehjcvp/pvaa010
Reviews
A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
Abhinav Grover and Mansi Oberoi
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 2, March 2021, Pages 148–157, https://doi.org/10.1093/ehjcvp/pvaa064
Left ventricular thrombosis: new perspectives on an old problem
Mauro Massussi and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 2, March 2021, Pages 158–167, https://doi.org/10.1093/ehjcvp/pvaa066
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals